Advances in detection, prevention and treatment of heart failure in type 2 diabetes: part I ALICE C COWLEY, ABHISHEK DATTANI, EMER M BRADY, GERRY P MCCANN, GAURAV S GULSIN Department of Cardiovascular Science, University of Leicester and the NIHR Biomedical Research Centre, Glenfield Hospital, Leicester, UK Address for correspondence: Dr Gaurav S Gulsin Department of Cardiovascular Science, University of Leicester and the NIHR Biomedical Research Centre, Glenfield Hospital, Groby Road, Leicester, LE3 9QP, UK E-mail: [email protected] Abstract Management of heart failure (HF) in diabetes has previously centred on aggressive control of cardiovascular risk factors
Incorporate BPC-157 cautiously
Clinical effects of L-carnitine supplementation on physical performance in healthy subjects, the key to success in rehabilitation: a systematic review and meta-analysis from the rehabilitation point of view
If you have commercial health insurance, you may be able to get Foundayo for just $25 per month
519 have shown that human PIWIL1 in apo state (without piRNA binding), acts as a co-activator of anaphase promoting complex/cyclosome (APC/C) E3 complex, which in turn selectively targets a cell adhesion-related protein, Pinin, for degradation and enhances pancreatic ductal carcinoma (PDAC) metastasis
